Cancer Patients Rarely Demand Unnecessary Treatment, Tests

This article originally appeared here.
Share this content:
Cancer Patients Rarely Demand Unnecessary Treatment, Tests
Cancer Patients Rarely Demand Unnecessary Treatment, Tests

(HealthDay News) -- Cancer patients rarely request unnecessary tests or treatments, according to a study published online Feb. 12 in JAMA Oncology.

Researchers surveyed 34 oncologists, 11 oncology fellows, and 15 nurse practitioners immediately after visits with cancer patients at three Philadelphia hospitals between October 2013 and June 2014. Only 440 of the 5,050 visits (about 9 percent) included patient requests for tests or treatments. Of those, health care providers complied with 365 of the clinically appropriate requests. In addition, there were 50 demands for unnecessary tests or treatments, and health care providers complied with only seven of those demands.

About half of the patient requests (49.1 percent) were for medical imaging tests, 13.6 percent were for laboratory tests, and 5.2 percent were for genetic tests or chemosensitivity tests. More than 15 percent of patient requests were for palliative care treatments such as pain and sleep medicines (15.5 percent), 3.6 percent of patient requests were for chemotherapy, and 0.7 percent of requests were for costly proton beam therapy. Patients most likely to demand or request tests or treatments included those who had poor relationships with their health care providers and those on active therapy.

The findings show that doctors "have to stop blaming patients for being demanding. In reality, it is hardly happening," Anthony Back, M.D., of the Seattle Cancer Care Alliance, writes in an accompanying editorial. "The myth of the demanding patient is more about our own responses and how lackluster communication skills can contribute to difficult situations that stick in our throats and in our memories. And when we have calmed down enough to look up, we see that what is really happening between patients and physicians these days is something quite different."

Abstract
Full Text
Editorial

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »